US Stock Market Has Yet to Find a Bottom

image

(Bloomberg) — The S&P 500 Index still hasn’t bottomed yet despite its 7% plunge over the last three weeks, according to a group of strategists at Bank of America Corp. led by Savita Subramanian.

The bank’s so-called bull-market signposts suggest the broad US equities benchmark hasn’t reached full capitulation, with just 40% of BofA’s signals being triggered. US stocks still don’t look cheap enough for investors to start piling in, with the US economy still in the early stages of downturn, according to the strategists.

“History suggests it’s better to be late than early,” Subramanian, BofA’s head of US equity and quantitative strategy, wrote in a note to clients. “We recommend waiting for more bull market signals.”

The strategists analyzed different macro and bottom-up data, including Fed policy, equity valuation, economic growth, investor sentiment and technical trends to determine what typically occurs ahead of a market bottom. Of the 10 consistent triggers, only 4 have been reached. In the past seven market bottoms, at least 80% were hit.

There have been glimmers of hope, however, with sentiment and technical indicators improving and turning mostly bullish. Although corporate earnings in the second quarter were better than feared, the market remains vulnerable, Subramanian said. She reaffirmed the bank’s year-end price target of 3,600 earlier this week. That’s 9% below its close at 3,966.85 on Thursday.

Although the unemployment rate rose to 3.7% in August, which typically happens before market bottoms, the average lag between initial rise in unemployment and market bottom has been 13 months, according to the bank.

“Valuations for the S&P 500 are rich on almost every measure we track,” Subramanian said. “With no real signs of a bull market, we view the 17% rally off the June low as a bear market rally.”

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More